Physician profile
Amber Larue Queen
NPI 1194033860
$10,420.33
in general payments reported to CMS, 2019-2025
35 companies · $2,814 in 2025
The $2,814 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,440 · 2022: $1,713 · 2023: $2,042 · 2024: $2,412 · 2025: $2,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,226 · Education: $41.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,225.50 |
| Education | $41.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,837.62 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Actelion Pharmaceuticals US, INC. | $1,205.60 | 2021-2025 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $1,145.76 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $761.92 | 2021-2025 | Ofev, Stiolto Respimat |
| Harmony Biosciences LLC | $569.34 | 2022-2025 | Wakix |
| United Therapeutics Corporation | $544.01 | 2021-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $493.08 | 2021-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $489.02 | 2021-2025 | Glassia |
| Electromed, INC. | $405.12 | 2021-2025 | Smartvest |
| Amgen INC. | $317.04 | 2022-2025 | Tezspire |
| Philips North America LLC | $295.44 | 2021-2024 | (Ak6) Vest Therapy |
| Grifols USA, LLC | $274.68 | 2021-2024 | Prolastin-C Liquid |
| Insmed, INC. | $240.78 | 2024-2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $232.27 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $204.36 | 2022-2025 | Acthar |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $193.07 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Baxter Healthcare | $184.79 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $180.65 | 2023-2025 | Winrevair, Keytruda |
| Pulmonx Corporation | $140.00 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Inspire Medical Systems, INC. | $135.19 | 2025 | Inspire |
| Genzyme Corporation | $94.87 | 2024-2025 | |
| Genentech USA, INC. | $77.90 | 2021-2022 | |
| Verona Pharma, INC. | $76.88 | 2025 | Ohtuvayre |
| Penumbra, INC. | $65.18 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $49.27 | 2024-2025 | Lumryz |
| Lilly USA, LLC | $39.76 | 2025 | Mounjaro, Zepbound |
| Mylan Specialty L.P. | $31.92 | 2024 | Yupelri |
| Resmed Corp | $21.72 | 2023 | |
| Advanced Respiratory, INC | $20.21 | 2021 | |
| Boston Scientific Corporation | $17.77 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.18 | 2024 | Xarelto |
| Sandoz INC. | $16.83 | 2022 | |
| Fisher & Paykel Healthcare INC | $14.68 | 2021 | |
| Hikma Pharmaceuticals USA | $13.75 | 2024 | Ryaltris |
| Phadia US INC. | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Queen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.